Medexus Pharmaceuticals Inc.
MEDXF
$1.77
-$0.01-0.56%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 566.36% | -94.38% | 156.82% | 242.70% | 51.14% |
| Total Depreciation and Amortization | 11.42% | 11.77% | -2.69% | 0.07% | -1.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.21% | 48.36% | 134.36% | -7.62% | -73.17% |
| Change in Net Operating Assets | -16.30% | -35.15% | 244.84% | -147.04% | 26.00% |
| Cash from Operations | -2.12% | -16.33% | 409.83% | -71.00% | -24.62% |
| Capital Expenditure | -64.86% | -15.63% | -1,500.00% | 50.00% | 75.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 15.73% | 0.00% | -39.06% | 81.68% | -203.30% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.28% | -- | -- | -- | -- |
| Cash from Investing | 83.94% | -525.16% | 11.34% | 69.27% | -195.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 19.27% | -23.88% | -24.64% | 93.16% | -1,992.35% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 12.05% | -10.30% | 10.20% | -30.41% | 10.19% |
| Cash from Financing | 17.60% | -20.44% | -13.51% | 73.88% | -411.75% |
| Foreign Exchange rate Adjustments | -603.33% | 372.73% | 67.16% | -183.75% | 202.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 199.12% | -146.30% | 208.15% | 73.80% | -403.52% |